Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-06

Clinical Trial Update: Disulfiram for Treatment of Retinal Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial at the University of Washington is evaluating disulfiram as a treatment for inherited retinal dystrophy involving the sensory retina …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disulfiram (Disulfiram)

Snippet

Sponsor: University of Washington | Conditions: Inherited Retinal Dystrophy Primarily Involving Sensory Retina | Phase 1, Phase 2 | Status: RECRUITING